Using a large US hospital database, we describe 192Candida auris‒associated hospitalizations during 2017–2022, including 38 (20%)C. aurisbloodstream infections. Hospitalizations involved extensive concurrent conditions and healthcare use; estimated crude mortality rate was 34%. These findings underscore the continued need for public health surveillance andC. auriscontainment efforts.